American Healthcare REIT, Inc. (AHR)
NYSE: AHR · IEX Real-Time Price · USD
13.88
+0.15 (1.09%)
May 1, 2024, 4:00 PM EDT - Market closed
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for AHR stock have an average target of 16, with a low estimate of 14 and a high estimate of 18. The average target predicts an increase of 15.27% from the current stock price of 13.88.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AHR stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '24 | May '24 |
|---|---|---|
| Strong Buy | 1 | 1 |
| Buy | 5 | 5 |
| Hold | 1 | 1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $17 → $16 | Strong Buy | Maintains | $17 → $16 | +15.27% | Apr 3, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +22.48% | Mar 25, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +15.27% | Mar 25, 2024 |
| Barclays | Barclays | Buy Initiates $18 | Buy | Initiates | $18 | +29.68% | Mar 14, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $15 | Buy | Initiates | $15 | +8.07% | Mar 4, 2024 |
Financial Forecast
Revenue This Year
2.00B
from 1.87B
Increased by 7.04%
Revenue Next Year
2.14B
from 2.00B
Increased by 7.06%
EPS This Year
-0.21
from -1.08
EPS Next Year
-0.06
from -0.21
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 2.1B | 2.3B |
| Avg | 2.0B | 2.1B |
| Low | 1.9B | 2.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 11.3% | 14.5% |
| Avg | 7.0% | 7.1% |
| Low | 2.3% | -0.5% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -0.22 | -0.06 |
| Avg | -0.21 | -0.06 |
| Low | -0.21 | -0.06 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.